Fresenius SE KGaAXSWX:FRE 70 Earnings Yield (Joel Greenblatt) % is 7.58% as of Mar. 2026, which is 3% above its 10-year median of 7.34. GuruFocus rates XSWX:FRE with a GF Score™ of 70/100 and a GF Value™ of CHF33.42 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Fresenius SE KGaA ranks better than 76.57% on this metric.
Fresenius SE KGaA's Enterprise Value for the quarter that ended in Mar. 2026 was CHF30,735 Mil.
Fresenius SE KGaA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF2,366 Mil. Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 7.58%.
The historical rank and industry rank for Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XSWX:FRE'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.94 Med: 7.34 Max: 11.24
Current: 8.03
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Fresenius SE KGaA was 11.24%. The lowest was 2.94%. And the median was 7.34%.
XSWX:FRE's Earnings Yield (Joel Greenblatt) % is ranked better than 76.57% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 3.43
vs XSWX:FRE: 8.03
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Fresenius SE KGaA's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was -7.65%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Fresenius SE KGaA (XSWX:FRE) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Fresenius SE KGaA Earnings Yield (Joel Greenblatt) % Related Terms
Fresenius SE KGaA Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA Earnings Yield (Joel Greenblatt) % Chart
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Earnings Yield (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % falls into.
Fresenius SE KGaA Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Fresenius SE KGaAs Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Fresenius SE KGaA's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2,366 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 7.58% mean?
Fresenius SE KGaA (XSWX:FRE) has a Earnings Yield (Joel Greenblatt) % of 7.58% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Fresenius SE KGaA and its competitors. This is near median its historical median of 7.34. Over the past decade, Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % has ranged from 2.94 to 11.24. According to the industry distribution chart, Fresenius SE KGaA ranks #160 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 23.4%.
Is Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % too high?
Fresenius SE KGaA's current Earnings Yield (Joel Greenblatt) % of 7.58% is near median its 10-year median of 7.34. Over the past 10 years, this metric has ranged from a low of 2.94 to a high of 11.24. The Healthcare Providers & Services industry median Earnings Yield (Joel Greenblatt) % is 3.43. Fresenius SE KGaA's value of 7.58% is 121% above this industry median. Based on the distribution chart, Fresenius SE KGaA ranks #160 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius SE KGaA has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Earnings Yield (Joel Greenblatt) % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius SE KGaA ranks #160 out of 683 companies for Earnings Yield (Joel Greenblatt) %. This places Fresenius SE KGaA in the top 23% of its industry — outperforming the majority of peers. The industry median Earnings Yield (Joel Greenblatt) % is 3.43. Fresenius SE KGaA's value of 7.58% is 121% above this benchmark. Historically, Fresenius SE KGaA's own Earnings Yield (Joel Greenblatt) % has ranged from 2.94 to 11.24 over the past decade. While the company's 10-year median is 7.34 vs. the industry median of 3.43, Fresenius SE KGaA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median Earnings Yield (Joel Greenblatt) % among Healthcare Providers & Services companies is 3.43, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius SE KGaA's current Earnings Yield (Joel Greenblatt) % of 7.58% is 121% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Fresenius SE KGaA and its competitors. For the Healthcare Providers & Services industry, the median Earnings Yield (Joel Greenblatt) % is 3.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius SE KGaA's current Earnings Yield (Joel Greenblatt) % is 7.58%, which is near median its own 10-year median of 7.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF33.42, compared to a current price of CHF37.79 — trading 13.1% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 7.58%, which is near median its 10-year median of 7.34 and 121% above the Healthcare Providers & Services industry median of 3.43. Fresenius SE KGaA's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Earnings Yield (Joel Greenblatt) % is 7.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF37.79 is trading 13.1% above its estimated GF Value™ of CHF33.42.
GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.
Key valuation signals for XSWX:FRE:
Earnings Yield (Joel Greenblatt) %: 7.58% (near median its 10-year median of 7.34)
GF Value™: CHF33.42 vs. price of CHF37.79 (13.1% above fair value)
Industry Position: 121% above the Healthcare Providers & Services median (#160 of 683)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
70GF Score
Get the complete analysis for XSWX:FRE
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
